🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the safety, tolerability, and immun...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2021-07-08
Trial ID
NCT04927585
Treatments Being Tested
P27A study is designed as a randomized phase Ia/Ib trial to evaluate the sa...
Status
Completed
Location
CHUV CRC
Start Date
2014-03
Trial ID
NCT01949909
Treatments Being Tested
This study evaluates the efficacy, safety and immunogenicity of different f...
Status
Completed
Location
George Washington University
Start Date
2018-03-01
Trial ID
NCT03172975
This protocol is for a phase 1, randomized, single-blinded study to evaluat...
Status
Completed
Location
Rockefeller University
Start Date
2012-09
Trial ID
NCT01864876
Treatments Being Tested
This pilot phase I clinical trial studies the side effects and best dose of...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2014-11-17
Trial ID
NCT02180698
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Alabama CRS
Start Date
2017-08-22
Trial ID
NCT03220724
This is a single arm, open-label, single center study evaluating the safety...
Status
Completed
Location
University of Washington Medical Center, Seattle Cancer Care Alliance
Start Date
2014-01
Trial ID
NCT02035657
Treatments Being Tested
The goal of this study is to evaluate the safety, tolerability and immunoge...
Status
Completed
Location
Research Site
Start Date
2015-01-05
Trial ID
NCT02289820
The purpose of this study is to evaluate the experimental tuberculosis (TB)...
Status
Unknown
Location
Ajou University Hospital
Start Date
2018-05-31
Trial ID
NCT03806686
Treatments Being Tested
This study evaluated the safety and immune response in healthy HIV-exposed ...
Status
Completed
Location
Perinatal HIV Research Unit (PHRU), Soweto CRS
Start Date
2020-11-10
Trial ID
NCT04607408
Treatments Being Tested